Pandey Roma, Kharb Anjali, Sharma Ashish, Sood Hemant, Chauhan Rajinder Singh
Department of Biotechnology, School of Engineering & Applied Sciences, Bennett University, Greater Noida, Uttar Pradesh, 201310, India.
Department of Biotechnology & Bioinformatics, Jaypee University of IT, Solan, HP, 173215, India.
Biochem Genet. 2024 Sep 23. doi: 10.1007/s10528-024-10930-2.
Picrorhiza kurroa is a valuable medicinal herb of Himalayan region, containing two major pharmacological iridoid glycosides: Picroside-I and Picroside-II, in addition to several other secondary metabolites. The metabolic diversity of P. kurroa may stem from the evolutionary processes attributed to pathway genes family expansion via gene duplication or splicing giving rise to paralogues which are further controlled by regulatory components. Occurrence of multiple pathway gene paralogues coupled with which TFs associate with paralogues in different genetic backgrounds (populations) in tissue-specific manner are still unresolved. Here, we unravelled possible correlations between TFs and gene paralogues across a range of P. kurroa accessions which might be contributing to differential contents of Picroside-I and Picroside-II in different tissues/organs. Characterization of shoots, roots, and stolons of eighty-five accessions of P. kurroa revealed significant variations for Picroside-I and Picroside-II contents. Comparative transcriptome analysis of shoot-derived transcriptome (PKSS), and root-derived transcriptome (PKSR) followed by their expression analysis in different P. kurroa accessions revealed TFs; PkWRKY71, PkWRKY12, PkNAC25, and PkMyb46 possibly regulate different gene paralogues. Genes encoding these putative TFs and pathway gene paralogues were further used to generate a robust co-expression network, thereby, uncovering their coordinated behaviour in association with Picroside-I and Picroside-II contents in shoots and roots, respectively. The outcome has provided potential leads, which through further functional validation can provide suitable targets, either for pathway engineering or as gene markers for selection of genetically superior populations of P. kurroa.
胡黄连是喜马拉雅地区一种珍贵的药用植物,除了几种其他次生代谢产物外,还含有两种主要的具有药理活性的环烯醚萜苷:胡黄连苷-I和胡黄连苷-II。胡黄连的代谢多样性可能源于进化过程,这一过程归因于通过基因复制或剪接导致途径基因家族扩张,从而产生旁系同源物,这些旁系同源物进一步受调控成分控制。多个途径基因旁系同源物的出现,以及哪些转录因子在不同遗传背景(种群)的组织特异性方式下与旁系同源物相关联,仍然没有得到解决。在这里,我们揭示了一系列胡黄连种质中转录因子和基因旁系同源物之间可能的相关性,这些相关性可能导致不同组织/器官中胡黄连苷-I和胡黄连苷-II含量的差异。对85份胡黄连种质的茎、根和匍匐茎进行表征,发现胡黄连苷-I和胡黄连苷-II含量存在显著差异。对茎来源的转录组(PKSS)和根来源的转录组(PKSR)进行比较转录组分析,随后在不同胡黄连种质中进行表达分析,结果显示转录因子PkWRKY71、PkWRKY12、PkNAC25和PkMyb46可能调控不同的基因旁系同源物。编码这些假定转录因子和途径基因旁系同源物的基因进一步用于构建一个强大的共表达网络,从而揭示它们分别与茎和根中胡黄连苷-I和胡黄连苷-II含量相关的协同行为。这一结果提供了潜在的线索,通过进一步的功能验证,可以为途径工程提供合适的靶点,或者作为选择胡黄连优良遗传种群的基因标记。